1. Mechanisms of NSAID-Induced Gastroenteropathy

   • Allan H. Price
   • Michael Fletcher

   Section 1: A Review 27 November 2012 Pages: 1 - 11

2. Is There a Rational Basis for the Different Spectra of Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)?

   • K. Brune

   Section 2: Symposium on NSAIDs 27 November 2012 Pages: 12 - 15

3. Nonsteroidal Anti-Inflammatory Drug Therapy and Gastric Side Effects

   • P. Dandona
   • J. Y. Jeremy

   Section 2: Symposium on NSAIDs 27 November 2012 Pages: 16 - 24

4. NSAID Gastropathy

   • Sanford H. Roth

   Section 2: Symposium on NSAIDs 27 November 2012 Pages: 25 - 28

5. A Microcomputer-Assisted Study of Nabumetone and Slow Release Diclofenac in Osteoarthritis

   • D. Laws
   • S. Saul
   • B. Fehilly

   Section 2: Symposium on NSAIDs 27 November 2012 Pages: 29 - 33

6. An Overview of the Long Term Safety Experience of Nabumetone

   • R. F. Willkens

   Section 2: Symposium on NSAIDs 27 November 2012 Pages: 34 - 37

7. German Drug Monitoring Studies with Nabumetone

   • I. Stroehmann
   • Martin Fedder
   • H. Zeidler

   Section 2: Symposium on NSAIDs 27 November 2012 Pages: 38 - 42

8. Profile of a Large-Scale Cohort Study

   • A. P. Fletcher

   Section 2: Symposium on NSAIDs 27 November 2012 Pages: 43 - 47

9. Meta-Analysis of Italian Clinical Trials of Nabumetone

   • G. Vaiani
   • E. Grossi

   Section 2: Symposium on NSAIDs 27 November 2012 Pages: 48 - 49

10. Efficacy and Safety of Nabumetone in Patients with Rheumatic Diseases

    • I. Stroehmann
    • K. H. Giersch
    • P. Münzel

    Section 2: Symposium on NSAIDs 27 November 2012 Pages: 50 - 52

11. Effects of the Prodrug Nabumetone, and its Active Metabolite, 6-MNA, on Human and Rat Gastric Mucosal Prostanoids and Platelet Function

    • J. Y. Jeremy
    • D. P. Mikhailidis
    • P. Dandona

    Section 2: Symposium on NSAIDs 27 November 2012 Pages: 53 - 56

12. Penetration of the Active Metabolite of Nabumetone into Synovial Fluid and Adherent Tissue of Patients Undergoing Knee Joint Surgery

    • R. K. Miehlke
    • S. Schneider
    • P. Münzel

    Section 2: Symposium on NSAIDs 27 November 2012 Pages: 57 - 61

13. Efficacy and Safety of Nabumetone in 4541 Elderly Patients From a Drug Monitoring Study

    • P. Münzel
    • E. E. Lemmel

    Section 2: Symposium on NSAIDs 27 November 2012 Pages: 62 - 64

14. Effect of Nabumetone on Patients with RA Evaluated by Isokinetic Muscle Strength

    • A. N. Gam
    • A. Nawrocki
    • B. Danneskiold-Samsøe

    Section 2: Symposium on NSAIDs 27 November 2012 Pages: 65 - 66

15. Nabumetone

    • M. A. Brett
    • G. Buscher
    • A. R. Thawley

    Section 2: Symposium on NSAIDs 27 November 2012 Pages: 67 - 70

16. Analgesic Activity of Nabumetone in Postoperative Pain

    • Piergiacomo Movilia
    • Luigi Restelli
    • Enzo Grossi

    Section 2: Symposium on NSAIDs 27 November 2012 Pages: 71 - 74

17. Efficacy and Safety of Nabumetone in 5421 Patients with Osteoarthritis of the Hip and/or Knee Joints

    • M. Fedder
    • I. Stroehmann

    Section 2: Symposium on NSAIDs 27 November 2012 Pages: 75 - 77

18. Analgesic Activity of Nabumetone Versus Naproxen in Acute Exacerbation of Osteoarthritis

    • M. Cazzola
    • F. Montrone
    • I. Caruso

    Short Communication 27 November 2012 Pages: 78 - 79

19. A 12-Month Postmarketing Surveillance Study of Nabumetone

    • P. N. Jenner

    Section 2: Symposium on NSAIDs 27 November 2012 Pages: 80 - 86

20. Chairman’s Summary

    • G. S. Panayi

    Section 2: Symposium on NSAIDs 27 November 2012 Pages: 87 - 87